Is it Time to Buy? Analysts Weighing in on These Shares: Community Health Systems, Inc. (NYSE:CYH), Amgen Inc. (NASDAQ:AMGN)

According to data provided by Zacks Research, Community Health Systems, Inc. (NYSE:CYH) has a consensus target price of $N/A on the stock. Out of the polled analysts providing targets, the high is currently $N/A, while the low is resting at $N/A. Analyst price targets may vary depending on the individual method used to calculate the estimate.
Turning to earnings, analysts are expecting Community Health Systems, Inc. (NYSE:CYH) to post a current quarter EPS of $N/A. This consensus number is compiled by Zacks Research. For the period ending on N/A, the company reported EPS for the quarter of $N/A. The resulting surprise factor from the difference between the reported number and the consensus estimate going into earnings was N/A%. After a company reports earnings, the stock may see increased activity. The next earnings report date is scheduled on or near N/A.
In terms of analyst ratings, Community Health Systems, Inc. (NYSE:CYH) has a current ABR of N/A. This average broker recommendation is given by Zacks using a scale from 1 to 5. According to this scale, a rating of 1 or 2 would indicate a Buy, and a rating of 4 or 5 would signify a Sell recommendation. A 3 would indicate a Hold on the stock.

During the most recent trading session, Amgen Inc. (NASDAQ:AMGN) shares traded -1.04%. Tracking the stock price in relation to moving averages may provide enhanced perspective on stock performance. After a recent look, the stock has been seen trading $12.16 off of the 50-day moving average of $175.31 and $18.15 separated from the 200-day moving average of $169.32. Taking a further look from a different perspective, the stock has been recently recorded -1.90% off of the 52-week high of 191.10 and +40.28% apart from the 52-week low of 133.64. Monitoring stock price activity relative to moving averages and the highs and lows for the past year might help with future stock price value assessment. 

Price Target in Focus

While monitoring stock technicals is important, most investors are more concerned with where the stock might be going now.  Equity research analysts have provided views on where they believe the stock will be trading in the future. According to Thomson Reuters, sell-side analysts are projecting a consensus target price of $187.25 on company shares. This is a near-term estimate for the next 12-18 months.

Currently, Amgen Inc. has a price to earnings ratio of 17.08. Analysts and investors may also opt to evaluate a company's PEG or price to earnings growth ratio. The stock currently has a PEG Ratio of 3.69.

By Standard Staff Contributor